Presentation EuroPCR 2024 Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial Presenter: Patrick Serruys May 15, 2024
News Conference News EuroPCR 2024 Myval Matches Contemporary TAVI at 30 Days, but Do More Sizes Matter? Shelley Wood May 15, 2024
Presentation EuroPCR 2024 Short Methodology Insight - LANDMARK Presenter: Davide Capodanno May 14, 2024